We could not find any results for:
Make sure your spelling is correct or try broadening your search.
BRISTOL, TN -- (Marketwire) -- 02/08/11 -- King Pharmaceuticals, Inc. (NYSE: KG) (the "Company") announced today that it has submitted written notice to the New York Stock Exchange (the "NYSE") of...
BRISTOL, TN -- (Marketwire) -- 01/31/11 -- King Pharmaceuticals, Inc. (NYSE: KG) (the "Company") announced today that it has commenced a tender offer (the "Convertible Notes Tender Offer") to...
REMOXY® New Drug Application Accepted by the FDA with PDUFA Goal Date of June 23, 2011 PR Newswire CUPERTINO, Calif., Jan. 27, 2011 CUPERTINO, Calif., Jan. 27, 2011 /PRNewswire/ -- DURECT...
Zacks Analyst Blog Highlights: Pfizer, King Pharmaceuticals, Durect Pharma, Pain Therapeutics and Acura Pharmaceuticals PR Newswire CHICAGO, Jan. 25, 2011 CHICAGO, Jan. 25, 2011 /PRNewswire/...
Pfizer Inc. (PFE) again pushed back the expiration date of its tender offer to buy King Pharmaceuticals Inc. (KG), this time by a week as it seeks to complete the $3.6-billion deal for the...
BRISTOL, Tenn. and SAN MATEO, Calif., Dec. 27, 2010 (GLOBE NEWSWIRE) -- King Pharmaceuticals®, Inc. (NYSE:KG) and Pain Therapeutics®, Inc. (Nasdaq:PTIE) today announced that King has resubmitted...
King Pharmaceuticals Inc. (KG) resubmitted a New Drug Application for Remoxy, its abuse-resistant pain killer, to the U.S. Food and Drug Administration in response to a review letter received by...
REMOXY® New Drug Application Resubmitted PR Newswire CUPERTINO, Calif., Dec. 27, 2010 CUPERTINO, Calif., Dec. 27, 2010 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) today reported...
King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY® PR Newswire BRISTOL, Tenn. and SAN MATEO, Calif., Dec. 27, 2010 BRISTOL, Tenn. and SAN MATEO...
REHOVOT, ISRAEL and PHILADELPHIA, PA -- (Marketwire) -- 12/20/10 -- Rosetta Genomics, Ltd. ("Rosetta") (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions